Akèy › Timè nan sèvo › Distrik Columbia › Washington
Etid klinik pou Timè nan sèvo nan Washington, DC
20 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Washington (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Tumor Related Epilepsy
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Evaluation and Treatment of Neurosurgical Disorders
Ap rekriteEtid obsèvasyon
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Ap rekriteFaz 2
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Ap rekriteFaz 1/2
- Georgetown University Lombardi Cancer Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Vision Improvement Through Behavioral Rehabilitation And Neuroplasticity Training
Ap rekrite
- Georgetown University Medical Center, Washington D.C.
Home-based Vision Rehabilitation Guided by Brain Imaging
Ap rekrite
- Georgetown University Medical Center, Washington D.C.
NgFUS NIVO: NeuroNavigation-Guided Focused Ultrasound With Nivolumab in Relapsed and Progressive DMG and Other High Grade Brain Tumors
Ap rekriteFaz 1
- Children's National Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
Ap rekriteEtid obsèvasyon
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
Ap rekriteFaz 2
- Children's National Medical Center, Washington D.C.
A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors
Ap rekriteFaz 3
- NIH Clinical Center, Bethesda · 7 mi lwen
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
Ap rekriteFaz 1/2
- National Institutes of Health Clinical Center, Bethesda · 7 mi lwen
Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Ap rekrite
- Sibley Memorial Hospital, Washington D.C.
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
Ap rekriteVolontè an sante akeyi
- Sibley Memorial Hospital, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
Ap rekriteFaz 1
- Children's National Hospital, Washington D.C.
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
Ap rekriteFaz 3
- Walter Reed National Military Medical Center, Bethesda · 7 mi lwen
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Ap rekriteFaz 2
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Ap rekriteFaz 1/2
- Sibley Memorial Hospital, Washington D.C.
Pediatric Radiation Therapy Registry
Ap rekriteEtid obsèvasyon
- Sibley Memorial Hospital, Washington D.C.
Etid Timè nan sèvo nan lòt vil
- Houston, TX35 etid
- Boston, MA28 etid
- New York City, NY25 etid
- Los Angeles, CA16 etid
- Miami, FL15 etid
- Durham, NC14 etid
- St. Louis, MO12 etid
- Rochester, MN11 etid
- Chicago, IL11 etid
- Cleveland, OH11 etid
- Baltimore, MD11 etid
- Seattle, WA11 etid
Lòt etid nan Washington
- Kansè (tout kalite)58 etid
- Kansè Poumon ki pa ti selil55 etid
- Kansè nan tete46 etid
- Kansè Metastatik43 etid
- Kansè poumon41 etid
- Kansè pwostat38 etid
- Obèsite33 etid
- Kansè kolorektal29 etid
- Maladi kadyovaskilè28 etid
- Kansè vejik26 etid
- Leksemi mieloïd egi24 etid
- Kansè ovè23 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.